Home

Accurate, Accessible, and Affordable Breast Cancer Screening

Patents

Patents Issued/Assigned Rights:

First Warning Systems, Inc. is licensed by its parent company, Lifeline Biotechnologies. The license grants First Warning Systems, Inc. all rights, worldwide, for further product development, regulatory, manufacturing and marketing.

5,941,832 issued 8/24/99, Utility: Method and Apparatus for Detection of Cancerous and Precancerous Conditions in a Breast.

12/198,967 filed 8/27/09, Method/Process: A Device for Analyzing Thermal Data Based on Breast Surface Temperature for the Detection for Use in Determining Cancerous Conditions.

12/583,969 filed 8/27/09, utility: System for Analyzing Thermal Data Based on Breast Surface Temperature to Determine Suspect Conditions.

2/583,951 filed 8/27/09, utility: Methods for Collecting and Analyzing Thermal Data Based on Breast Surface Temperature to Determine Suspect Conditions.

Trademarks/Copyrights

Serial No. 78340830; Registration No. 2980880, Mark: First Warning

Regulatory – 510(K)’S

510(k) Number K881813: Issued by the FDA November 4, 1988 to Chronodynamics Ltd. Description: A Medical Device, as an Intelligent Portable Data Recorder for Skin Temperature Measurement. Up to 16 Sensors at Various Locations. Lifeline Biotechnologies, First Warning’s parent company, acquired the 510 (k) from Chronodynamics in the early 1990s.

Get in Touch

First Warning Systems, Inc. 1325 Airmotive Way, Ste 175-L Reno, NV 89502

Phone: 775-324-3822
Fax: 775-852-7551

Follow Us

twitter twitter